Position in AUTL
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$15,200,000
+$2,090,000 QoQ
Shares Held
9,500,000
0.0% QoQ
Ownership
3.57%
of shares outstanding
% of Portfolio
2.47%
of 13F equity value
Holder Rank
#5
of 84 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in AUTL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Tetragon Partners GP Ltd holds $170,564,204 across 22 Biotechnology names. AUTL ranks #1 (8.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AUTL |
Autolus Therapeutics plc
This page
|
9,500,000 | $15,200,000 | |
| 2 | DFTX |
Definium Therapeutics, Inc.
|
286,990 | $13,500,009 | |
| 3 | MBX |
MBX Biosciences, Inc.
|
203,543 | $11,235,573 | |
| 4 | CLDX |
Celldex Therapeutics, Inc.
|
290,441 | $10,807,309 | |
| 5 | RLAY |
Relay Therapeutics, Inc.
|
570,311 | $10,670,518 | |
| 6 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
130,484 | $10,635,750 | |
| 7 | PHVS |
Pharvaris N.V.
|
295,627 | $10,222,781 | |
| 8 | IMVT |
Immunovant, Inc.
|
255,934 | $9,861,137 |
All Filings in AUTL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,200,000 | 9,500,000 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $13,110,000 | 9,500,000 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $18,905,000 | 9,500,000 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $15,485,000 | 9,500,000 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $21,660,000 | 9,500,000 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $13,330,000 | 8,600,000 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $19,387,500 | 8,250,000 | Shares | Defined | 2025-02-21 | |
| 2024-09-30 | $29,040,000 | 8,000,000 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $27,840,000 | 8,000,000 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $48,013,851 | 7,525,682 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $51,520,000 | 8,000,000 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $27,960,000 | 12,000,000 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $28,560,000 | 12,000,000 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $18,400,000 | 10,000,000 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $15,770,000 | 8,300,000 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $6,504,275 | 3,039,381 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $8,544,938 | 3,019,413 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $11,784,157 | 2,825,937 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $14,013,000 | 2,700,000 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $16,375,000 | 2,500,000 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $16,600,000 | 2,500,000 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $13,956,641 | 2,435,714 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $19,221,000 | 2,150,000 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $25,026,000 | 2,150,000 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $34,464,500 | 2,150,000 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $11,875,779 | 1,982,601 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||